New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 4, 2013
15:33 EDTMDXGMiMedx reiterates FY14 revenue view $90M-$110M, consensus $99.8M
Revenues from the company's injectable are projected to be approximately 15% of the company's 2014 revenues.
News For MDXG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 16, 2014
09:17 EDTMDXGMiMedx Q4 results likely to beat consensus, says Needham
Subscribe for More Information
December 15, 2014
08:50 EDTMDXGMiMedx sees Q1 revenue $40M-$41M, consensus $39.26M
Sees Q1 operating profit margin to be in excess of 10%. Sees FY15 operating profit margin to be in excess of 15%.
08:48 EDTMDXGMiMedx raises FY15 revenue view to $190M from $175M, consensus $181.1M
Subscribe for More Information
December 11, 2014
09:35 EDTMDXGMiMedx management to meet with Needham
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use